 very strict rigid criteria in entry and exclusion criteria for clinical trials the way research agenda is set the care and meticulousness but long period of time that it takes to approve a drug worked well for other diseases but was particularly ill-suited for HIV where the people who became clinically ill had a median of 10 to 15 months to live